P053: Recurrent somatic copy number alterations and their association with gene expression levels on cancer genes in ovarian serous cystadenocarcinoma

P053: Recurrent somatic copy number alterations and their association with gene expression levels on cancer genes in ovarian serous cystadenocarcinoma

Bibliographic Details
Main Authors:	Hillary Esplen, Richard Yang, Awdhesh Kalia, Zhenya Tang, Guilin Tang, L. Jeffrey Medeiros, Gokce Toruner
Format:	Article
Language:	English
Published:	Elsevier 2023-01-01
Series:	Genetics in Medicine Open
Online Access:	http://www.sciencedirect.com/science/article/pii/S2949774423000729

Similar Items

Recurrent Somatic Copy Number Alterations and Their Association with Oncogene Expression Levels in High-Grade Ovarian Serous Carcinoma
by: Hillary P. Esplen, et al.
Published: (2023-11-01)

Mining TCGA database for gene expression in ovarian serous cystadenocarcinoma microenvironment
by: Youzheng Xu, et al.
Published: (2021-05-01)

Giant ovarian cystadenocarcinoma
by: Karell Piñón-García, et al.
Published: (2023-10-01)

Stem Cell-Associated Signatures Help to Predict Diagnosis and Prognosis in Ovarian Serous Cystadenocarcinoma
by: Li Li, et al.
Published: (2023-01-01)

The intratumoral microbiota biomarkers for predicting survival and efficacy of immunotherapy in patients with ovarian serous cystadenocarcinoma
by: Hao Qin, et al.
Published: (2024-07-01)

KRT19 is a Promising Prognostic Biomarker and Associates with Immune Infiltrates in Serous Ovarian Cystadenocarcinoma
by: Sun Z, et al.
Published: (2023-10-01)

13: Clinical utility of optical genome mapping as an additional tool to standard cytogenetic workup in hematological malignancies
by: Gokce Toruner, et al.
Published: (2025-01-01)

The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma
by: Philip Smith, et al.
Published: (2023-07-01)

ANGPTL4 accelerates ovarian serous cystadenocarcinoma carcinogenesis and angiogenesis in the tumor microenvironment by activating the JAK2/STAT3 pathway and interacting with ESM1
by: Yu-kun Li, et al.
Published: (2024-01-01)

Genome-wide quantification of copy-number aberration impact on gene expression in ovarian high-grade serous carcinoma
by: Sanaz Jamalzadeh, et al.
Published: (2024-02-01)

Hepatobiliary Cystadenocarcinoma
by: Neal Wilkinson
Published: (2012-01-01)

Significant Prognostic Factor at Age Cut-off of 73 Years for Advanced Ovarian Serous Cystadenocarcinoma Patients: Insights from Real-World Study
by: Zhang K, et al.
Published: (2024-02-01)

Author Correction: The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma
by: Philip Smith, et al.
Published: (2023-09-01)

Serous Cystadenocarcinoma Arising in Presumed Vitelline Duct Remnant: A Case Report and Implications in the Management of Cancer of Unknown Primary
by: Li Lei, et al.
Published: (2016-01-01)

Papillary cystadenocarcinoma of the sublingual gland
by: Neil Giblett, et al.
Published: (2017-09-01)

P583: Clinical utility of optical genome mapping as an additional test to standard cytogenetic workup of hematological malignancies
by: Gokce Toruner, et al.
Published: (2024-01-01)

Immunohistochemical Expression of p53 Gene and Clinicopathological Assessment of Low-grade Serous Ovarian Cancer and High-grade Serous Ovarian Cancer: A Cohort Study
by: Geeta Bazard, et al.
Published: (2024-12-01)

28: Intragenic KMT2A aberrations can be detected by optical genome mapping but require further biologic and clinical characterization
by: Zhenya Tang, et al.
Published: (2025-01-01)

MicroRNA gene expression profiling in human ovarian and primary peritoneal serous carcinomas
by: Flavin, R, et al.
Published: (2007)

MicroRNA gene expression profiling in human ovarian and primary peritoneal serous carcinomas
by: Flavin, R, et al.
Published: (2007)

Primary Pulmonary Mucinous Cystadenocarcinoma: A Case Report
by: Andreas Efstathiou, et al.
Published: (2011-01-01)

CDKN2D-WDFY2 is a cancer-specific fusion gene recurrent in high-grade serous ovarian carcinoma.
by: Kalpana Kannan, et al.
Published: (2014-03-01)

Genomic Copy Number Variation Affecting Genes Involved in the Cell Cycle Pathway: Implications for Somatic Mosaicism
by: Ivan Y. Iourov, et al.
Published: (2015-01-01)

Diagnostic and Treatment Errors in Biliary Cystadenomas and Cystadenocarcinomas: Clinical Cases
by: Kh. A. Ayvazyan, et al.
Published: (2022-12-01)

Radiomics nomogram for preoperative differentiation of early-stage serous borderline ovarian tumors and serous malignant ovarian tumors
by: Xinping Yu, et al.
Published: (2024-01-01)

Case report: Short-course hypofractionated radiation therapy combined with immune checkpoint inhibitors for the treatment of advanced ovarian mucinous cystadenocarcinoma
by: Xinan Wan, et al.
Published: (2025-01-01)

Differential microma expression in primary peritoneal serous carcinoma versus ovarian serous
by: O'Leary, J, et al.
Published: (2008)

Gene Copy-Number Alterations: A Cost-Benefit Analysis
by: Tang, Yun-Chi, et al.
Published: (2016)

Assessment of candidate high-grade serous ovarian carcinoma predisposition genes through integrated germline and tumour sequencing
by: Deepak N. Subramanian, et al.
Published: (2025-01-01)

Kinome capture sequencing of high-grade serous ovarian carcinoma reveals novel mutations in the JAK3 gene.
by: Lorenza Mittempergher, et al.
Published: (2020-01-01)

A novel defined programmed cell death related gene signature for predicting the prognosis of serous ovarian cancer
by: Feng Zhan, et al.
Published: (2024-04-01)

Molecular Analysis of High-Grade Serous Ovarian Carcinoma Exhibiting Low-Grade Serous Carcinoma and Serous Borderline Tumor
by: Kosuke Kanno, et al.
Published: (2024-08-01)

Differential microrna expression in primary peritoneal serous carcinoma versus ovarian serous carcinoma
by: O'Leary, J, et al.
Published: (2008)

Somatic Mutational Profile of High-Grade Serous Ovarian Carcinoma and Triple-Negative Breast Carcinoma in Young and Elderly Patients: Similarities and Divergences
by: Pedro Adolpho de Menezes Pacheco Serio, et al.
Published: (2021-12-01)

DNA cytosine deamination is associated with recurrent Somatic Copy Number Alterations in stomach adenocarcinoma
by: Yilin Shi, et al.
Published: (2023-10-01)

15.053 Introduction to Optimization, Spring 2002
by: Orlin, James B., 1953-
Published: (2002)

15.053 Introduction to Optimization, Spring 2004
by: Orlin, James B., 1953-
Published: (2004)

Evolution and vulnerabilities of somatic copy number alterations in cancer
by: Gibson, William J., Ph. D. Massachusetts Institute of Technology
Published: (2016)

Robustness of the Autophagy Pathway to Somatic Copy Number Losses
by: Pierfrancesco Polo, et al.
Published: (2022-05-01)

Integrative Analysis of Gene Expression and Promoter Methylation to Differentiate High-Grade Serous Ovarian Cancer from Benign Tumors
by: Ieva Vaicekauskaitė, et al.
Published: (2025-02-01)